Literature DB >> 17598490

Treatment of heterotopic ossification.

Samuel T Chao1, Michael J Joyce, John H Suh.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17598490     DOI： 10.3928/01477447-20070601-18

Source DB:  PubMed          Journal:  Orthopedics        ISSN： 0147-7447            Impact factor:   1.390


× No keyword cloud information.
  15 in total

1.  Heterotopic Ossification of the Finger Following Closed Blunt Trauma.

Authors:  Esther Wan Xian Tan; Sechachalam Sreedharan
Journal:  J Hand Microsurg       Date:  2014-08-28

2.  Inflammatory back pain due to heterotopic ossification.

Authors:  Gezmiş Kimyon; Yavuz Pehlivan
Journal:  Eur J Rheumatol       Date:  2014-09-01

3.  Delivery of siRNA silencing Runx2 using a multifunctional polymer-lipid nanoparticle inhibits osteogenesis in a cell culture model of heterotopic ossification.

Authors:  Swati Mishra; Asa D Vaughn; David I Devore; Charles M Roth
Journal:  Integr Biol (Camb)       Date:  2012-12       Impact factor: 2.192

4.  Nanogel-Mediated RNAi Against Runx2 and Osx Inhibits Osteogenic Differentiation in Constitutively Active BMPR1A Osteoblasts.

Authors:  Arun R Shrivats; Michael C McDermott; Molly Klimak; Saadyah E Averick; Haichun Pan; Krzysztof Matyjaszewski; Yuji Mishina; Jeffrey O Hollinger
Journal:  ACS Biomater Sci Eng       Date:  2015-09-25

5.  Botulinum Toxin-induced Muscle Paralysis Inhibits Heterotopic Bone Formation.

Authors:  Brandon J Ausk; Ted S Gross; Steven D Bain
Journal:  Clin Orthop Relat Res       Date:  2015-09       Impact factor: 4.176

Review 6.  Prophylactic Radiotherapy of Hip Heterotopic Ossification: A Narrative Mini Review.

Authors:  Massimiliano De Paolis; Alessio Giuseppe Morganti; Erika Galietta; Luca Gaiani; Claudio Giannini; Andrea Sambri; Milly Buwenge; Gabriella Macchia; Francesco Deodato; Savino Cilla; Lidia Strigari; Michele Fiore; Silvia Cammelli
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

7.  Heterotopic ossifications: role of radiotherapy as prophylactic treatment.

Authors:  Maria Grazia Ruo Redda; Chiara De Colle; Lavinia Bianco; Andrea Ruggieri; Daniela Nassisi; Annalisa Rossi; Eva Gino; Claudia Airaldi
Journal:  Radiol Med       Date:  2018-02-03       Impact factor: 3.469

Review 8.  A systematic review of the therapeutic interventions for heterotopic ossification after spinal cord injury.

Authors:  R W Teasell; S Mehta; J L Aubut; M C Ashe; K Sequeira; S Macaluso; L Tu
Journal:  Spinal Cord       Date:  2010-01-05       Impact factor: 2.772

Review 9.  Overactive bone morphogenetic protein signaling in heterotopic ossification and Duchenne muscular dystrophy.

Authors:  SongTing Shi; David J J de Gorter; Willem M H Hoogaars; Peter A C 't Hoen; Peter ten Dijke
Journal:  Cell Mol Life Sci       Date:  2012-07-04       Impact factor: 9.261

10.  Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-γ agonists.

Authors:  Kengo Shimono; Wei-En Tung; Christine Macolino; Amber Hsu-Tsai Chi; Johanna H Didizian; Christina Mundy; Roshantha A Chandraratna; Yuji Mishina; Motomi Enomoto-Iwamoto; Maurizio Pacifici; Masahiro Iwamoto
Journal:  Nat Med       Date:  2011-04-03       Impact factor: 53.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.